St Johns Hospital Of The Hospital Sisters Of The Third Order Of St F is located in Springfield, IL. The organization was established in 1946. According to its NTEE Classification (E22) the organization is classified as: General Hospitals, under the broad grouping of Health Care and related organizations. As of 06/2022, St Johns Hospital Of The Hospital Sisters Of The Third Order Of St F employed 3,330 individuals. This organization is a subordinate organization within an affiliated group for tax-exemption purposes. St Johns Hospital Of The Hospital Sisters Of The Third Order Of St F is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2021, St Johns Hospital Of The Hospital Sisters Of The Third Order Of St F generated $602.8m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 2.9% each year. All expenses for the organization totaled $568.9m during the year ending 06/2021. While expenses have increased by 2.1% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
HSHS ST. JOHN'S HOSPITAL PROVIDES A MINISTRY OF EXCEPTIONAL HEALTH CARE SERVICES TO THE PEOPLE OF CENTRAL ILLINOIS IN THE CATHOLIC TRADITION OF COMPASSION, JUSTICE AND REVERENCE FOR LIFE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
HSHS ST. JOHN'S HOSPITAL HAS ONE OF THE LARGEST HEART PROGRAMS IN ILLINOIS. WE ARE DEDICATED TO PROVIDING COMPASSIONATE CARE TO PATIENTS AND THEIR FAMILIES THAT MAKES US UNIQUE. IN 2022, HSHS ST. JOHN'S HAS CONTINUED TO BUILD THEIR STRUCTURED HEART PROGRAM. 150 PLUS TRANSCATHETER AORTIC VALVE REPLACEMENTS (TAVRS) HAVE BEEN COMPLETED THIS YEAR, ALONG WITH 95 WATCHMAN AND 24 MITRAL CLIP PROCEDURES. IN ADDITION, ST. JOHN'S CARDIAC PROGRAMS HAVE RECEIVED THE FOLLOWING AWARDS, DESIGNATIONS AND ACCOMPLISHMENTS: * HSHS ST. JOHN'S EARNED THE PLATINUM AWARD FROM THE NATIONAL CARDIOVASCULAR DATA REGISTRY FOR THE MI ACTION REGISTRY * HSHS ST. JOHN'S WAS THE FIRST HOSPITAL IN ILLINOIS TO RECEIVE THE ACCREDITATION FOR CARDIOVASCULAR EXCELLENCE FOR ITS CARDIAC CATHETERIZATION LAB. * HSHS ST. JOHN'S CARDIAC REHABILITATION DEPARTMENT IS AN AMERICAN ASSOCIATION OF CARDIOVASCULAR AND PULMONARY REHABILITATION (AACVPR) CERTIFIED PROGRAM OTHER INNOVATIONS THAT CONTINUE TO BE UTILIZED BY HSHS ST. JOHN'S HOSPITAL'S CARDIOVASCULAR SERVICES INCLUDE: * WATCHMEN PROCEDURE - USED TO REPLACE BLOOD THINNERS FOR PATIENTS WITH ATRIAL FIBRILLATION. * TAVR DEVICES - SMALLER, MORE EASILY DELIVERED CARDIAC VALVES IMPLANTED WITHOUT THE NEED FOR OPEN HEART SURGERY OR THE NEED FOR GENERAL ANESTHESIA. * ACURATE IDE - EVALUATE THE SAFETY AND EFFECTIVENESS OF THE ACURATE SYSTEM FOR TAVR IN SYMPTOMATIC SUBJECTS WHO HAVE SEVERE AORTIC VALVE STENOSIS AND WHO ARE AT INTERMEDIATE OR GREATER RISK FOR SURGICAL VALVE REPLACEMENT. * REBALANCE- ENDOVASCULAR ABLATION OF THE RIGHT GREATER SPLANCHNIC NERVE IN SUBJECTS HAVING HEART FAILURE WITH PRESERVED EJECTION FRACTION: RANDOMIZED CONTROLLED FEASIBILITY TRIAL * MITRACLIP - MINIMALLY INVASIVE REPAIR OF THE MITRAL VALVE, LEADING IMPLANT CENTER IN ILLINOIS . * PRAIRIE CARDIOVASCULAR CARDIOLOGISTS AT ST. JOHN'S HOSPITAL WERE THE FIRST TO ENROLL PATIENTS INTO LUTONIX'S LEVANT 2. LEVANT 2 IS A GLOBAL, RANDOMIZED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF THE MOXY DRUG COATED BALLOON COMPARED TO A STANDARD ANGIOPLASTY BALLOON FOR THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE. * CREST 2 - RANDOMIZED TRIAL COMPARING CAROTID SURGERY TO CAROTID STENTING. CREST 2 REGISTRY (C2R) - DESIGNED TO BE A COMPANION TO ACCOMPANY THE CREST-2 TRIAL; THE REGISTRY WILL PROMOTE RAPID INITIATION AND COMPLETION OF ENROLLMENT IN THE CREST-2 TRIAL, ENSURE THAT CAROTID ANGIOPLASTY AND STENTING (CAS) IS PERFORMED BY ADEQUATELY EXPERIENCED OPERATORS WITHIN CREST-2 AND C2R, CLOSELY MONITOR CLINICAL OUTCOMES * PERSUADE-HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) AND SYMPTOMATIC OBSTRUCTIVE ILIOFEMORAL VENOUS DISEASE AND VENOUS STENTING: * EVERA - UPDATED ICD TECHNOLOGY ALLOWING PATIENTS TO SAFELY UNDERGO MRI SCAN. * SOLVE CRT - STIMULATION OF THE LEFT VENTRICULAR ENDOCARDIUM FOR CARDIAC RESYNCHRONIZATION THERAPY IN NON-RESPONDERS AND PREVIOUSLY UNTREATABLE PATIENTS (WISE CRT SYSTEM). * MICRA - SMALLEST PACEMAKER AVAILABLE THAT REQUIRES NO LEADS OR GENERATOR EXTERNAL TO THE HEART. * AMPLATZER PFO OCCLUDER -POST APPROVAL - CONFIRM THE SAFETY AND EFFECTIVENESS OF THE AMPLATZER PFO OCCLUDER, IN A POST APPROVAL SETTING, IN PATIENTS WITH A PFO WHO HAVE HAD A CRYPTOGENIC STROKE CONFIRMED BY A STUDY NEUROLOGIST. * INTERRUPT AF - POST APPROVAL CLINICAL STUDY (PAS) TO EVALUATE OPEN IRRIGATED ABLATION CATHETERS WITH HIGH RESOLUTION MAPPING TO TREAT PAROXYSMAL ATRIAL FIBRILLATION. * ICLAS-CLINICAL STUDY TO EVALUATE THE SAFETY AND EFFICACY OF THE ADAGIO AF CRYOABLATION SYSTEM IN THE ABLATION TREATMENT OF SYMPTOMATIC PERSISTENT ATRIAL FIBRILLATION. DATA WILL SUPPORT A PRE-MARKET APPLICATION. * HEAL-A MULTI-CENTER STUDY EVALUATING PARTICIPANTS WHO RECEIVED CANGAROO ENVELOPE, TYRX ENVELOPE, OR NO ENVELOPE DURING CIED IMPLANTATION * CHAMPION-WATCHMAN FLX VERSUS NOAC FOR EMBOLIC PROTECTION IN THE MANAGEMENT OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION * EMPOWER-ASSESSMENT OF THE CARILLON MITRAL CONTOUR SYSTEM IN TREATING HEART FAILURE WITH FUNCTIONAL MITRAL REGURGITATION * ELEGANCE- DRUG ELUTING REGISTRY FOR REAL WORLD TREATMENT OF LESIONS IN THE PERIPHERAL VASCULATURE * C GUARDIAN-A MULTI-CENTER SINGLE ARM, PIVOTAL STUDY TO EVALUATE THE SAFETY AND EFFICACY OF THE CGUARD CAROTID STENT SYSTEM WHEN USED TO TREAT SYMPTOMATIC AND ASYMPTOMATIC CAROTID ARTERY STENOSIS IN PATIENTS UNDERGOING CAROTID ARTERY STENTING * REAL AF-REAL WORLD EXPERIENCE OF CATHETER ABLATION FOR THE TREATMENT OF SYMPTOMATIC PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION USING NOVEL CONTACT FORCE TECHNOLOGIES * SUMMIT - A PROSPECTIVE, CONTROLLED, MULTICENTER CLINICAL INVESTIGATION OF THE TENDYNE MITRAL VALVE SYSTEM FOR THE TREATMENTS OF ELIGIBLE SUBJECTS WITH SYMPTOMATIC, SEVERE MITRAL REGURGITATION. * OASIS 9/SYNERGY STENT REGISTRY - A 2X2 FACTORIAL RANDOMIZED CONTROLLED TRIAL OF COLCHICINE AND SPIRONOLACTONE IN PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION. * TARGET BP - A PIVOTAL, MULTICENTER, BLINDED, SHAM PROCEDURE-CONTROLLED TRIAL OF RENAL DENERVATION BY THE PEREGRINE SYSTEM KIT, IN SUBJECTS WITH HYPERTENSION. THE PURPOSE OF THIS STUDY IS TO OBTAIN AN ASSESSMENT OF THE EFFICACY AND SAFETY OF RENAL DENERVATION BY ALCOHOL-MEDIATED NEUROLYSIS USING THE PEREGRINE SYSTEM KIT IN UNCONTROLLED HYPERTENSIVE SUBJECTS WHEN USED IN COMBINATION WITH ANTIHYPERTENSIVE MEDICATIONS. IN ADDITION TO THE LIST OF CATHETERIZATION, SURGICAL AND NON-INVASIVE PROCEDURES BELOW, HSHS ST. JOHN'S OFFERS A CARDIAC REHABILITATION PROGRAM, AND OTHER STRESS-REDUCTION SERVICES THROUGH THE HSHS ST. JOHN'S CENTER FOR LIVING. CATHETERIZATION LABORATORY PROCEDURES ABDOMINAL AORTIC ANEURYSM GRAPHS ABLATION OF COMPLEX ARRHYTHMIAS ANGIOPLASTY WITH STENTING ATRIAL FIBRILLATION ABLATIONS BALLOON ANGIOPLASTY CARDIOMEMS CAROTID STENTS DEFIBRILLATOR IMPLANTATION DIAGNOSTIC CARDIAC CATHETERIZATION DRUG-ELUTING BALLOONS DRUG-ELUTING STENTS ELECTRO PHYSIOLOGIC EVALUATION OF COMPLEX ARRHYTHMIAS EVALUATION OF CARDIAC VALVES EVALUATION OF CONGENITAL HEART DISEASE INTRAVASCULAR ULTRASOUND AND OPTICAL COHERENCE TOMOGRAPHY LASER PACEMAKER LEAD EXTRACTION NEUROLOGICAL INTERVENTIONS FOR INTRA- CRANIAL ANEURYSMS AND ACUTE STROKE PACEMAKER IMPLANTATION PERIPHERAL VASCULAR STENTS RENAL STENTS SURGICAL PROCEDURES BEATING HEART BYPASS SURGERY CORONARY ARTERY BYPASS GRAFT SURGERY GENERAL THORACIC SURGERY HEART VALVE REPLACEMENT AND REPAIR MINIMALLY INVASIVE ATRIAL ABLATION SURGERY MINIMALLY INVASIVE VALVE REPLACEMENT REPAIR SURGERY PACEMAKER AND DEFIBRILLATOR IMPLANTATION SUTURELESS AVR VASCULAR SURGERY (AORTIC, CEREBROVASCULAR, RENAL, AND PERIPHERAL) NONINVASIVE CARDIOVASCULAR DIAGNOSTIC PROCEDURES A-V OPTIMIZATION CARDIAC CT ANGIOGRAPHY AND FUNCTIONAL TESTING AS AN ALTERNATIVE TO STRESS TESTING CARDIAC AND VASCULAR ULTRASOUND CARDIOVERSIONS DOPPLER EXAMS ECHOCARDIOGRAPHY INCLUDING 3D ELECTROCARDIOGRAMS HOLTER MONITORING/ARRHYTHMIA MONITORING/PACEMAKER CHECKS NUCLEAR AND ECHO STRESS TESTING PEDIATRIC CARDIOLOGY CLINIC PREADMISSION TESTING (CHEST X-RAYS AND BLOOD TESTS) TRAN ESOPHAGEAL ECHOCARDIOGRAPHY INCLUDING 3D THE HEART FAILURE DEPARTMENT COMING IN 2023, AT DISCHARGE PATIENTS WILL BE OFFERED ENROLLMENT IN THE HEART FAILURE REMOTE PATIENT MONITORING PROGRAM WHICH MONITORS PATIENTS' SYMPTOMS, DAILY WEIGHTS AND OTHER CLINICAL DATA REMOTELY TO HELP AVOID READMISSION. THE CARDIAC REHABILITATION DEPARTMENT AT HSHS ST. JOHN'S OFFERS PHASE 1 INPATIENT CARDIAC REHAB PHASE 2 OUTPATIENT CARDIAC REHAB - COMING IN 2023, TRANSITION TO BECOME A CERTIFIED PRITIKIN INTENSIVE CARDIAC REHAB PROVIDER PHASE 3 OUTPATIENT CARDIAC REHAB PHASE 3 OUTPATIENT PULMONARY REHAB SUPERVISED EXERCISE THERAPY FOR PERIPHERAL ARTERY DISEASE (SET FOR PAD)
ST. JOHN'S OTHER SPECIALIZED SERVICES INCLUDE CANCER CARE, WOMEN'S SERVICES, A NEUROSCIENCES INSTITUTE, HOME HEALTH, HOSPICE, AN EMERGENCY DEPARTMENT THAT NEARLY 54,000 PEOPLE PER YEAR SEEK CARE IN AND THE ST. JOHN'S CHILDREN'S HOSPITAL. OUR CHILDREN'S HOSPITAL IS THE ONLY COMPREHENSIVE CHILD HEALTH CARE FACILITY IN SOUTH-CENTRAL ILLINOIS AND PROVIDES VITAL HEALTH CARE FOR THE REGION'S CHILDREN, FROM INFANCY THROUGH AGE 18. RECOGNIZED BY THE CHILDREN'S HOSPITAL ASSOCIATION AND A MEMBER OF THE ASSOCIATION OF ILLINOIS CHILDREN'S HOSPITALS, ST. JOHN'S CHILDREN'S HOSPITAL OFFERS A WIDE RANGE OF SERVICES FOR CHILDREN AND THEIR FAMILIES BOTH HERE AT OUR FACILITIES AND EXTENDING INTO THE HOME. SERVICES INCLUDE: - GENERAL PEDIATRIC BEDS, WITH PRIVATE BATH, SHOWER AND PARENTAL SLEEPING AREA - PEDIATRIC ICU - PEDIATRIC HEMATOLOGY/ONCOLOGY - LEVEL III NEONATAL ICU - PEDIATRIC EMERGENCY ROOM SERVICES - NEONATAL AND PEDIATRIC TRANSPORTATION - THE ONLY REGIONAL LEVEL III PERINATAL CARE CENTER IN THE AREA - CHILD AND FAMILY SUPPORT AND SERVICES THROUGH OUR CHILD LIFE SPECIALISTS AND SOCIAL AND SPIRITUAL SERVICES DEPARTMENTS. - COMPREHENSIVE OUTPATIENT SERVICES SUCH AS HOME HEALTH, CHILDREN'S REHABILITATION CENTER AND EARLY INTERVENTION PROGRAM - A RONALD MCDONALD HOUSE ON SITE
AT HSHS ST. JOHN'S HOSPITAL, OUR MAIN OR SERVICES INPATIENTS AND OUTPATIENTS FROM THROUGHOUT CENTRAL ILLINOIS AND THE SURROUNDING COMMUNITIES. SURGEONS FROM SEVEN PHYSICIAN GROUPS PERFORM PROCEDURES AT OUR FACILITY, FROM SEVERAL SPECIALTIES, INCLUDING: PLASTICS, GENERAL SURGERY, GENERAL PEDIATRIC SURGERY, UROLOGY, PEDIATRIC UROLOGY, GYNECOLOGICAL SURGERY, GYNE-ONC SURGERY, ENT, NEUROSURGERY, OPHTHALMOLOGICAL SURGERY (INCLUDING RETINAL), AND ROBOTIC SURGERY. MAJOR PLASTICS PROCEDURES: * CLEFT PALATE/CLEFT LIP REPAIRS * BREAST RECONSTRUCTION * PEDIATRIC & ADULT BURN CARE MAJOR GENERAL SURGERY PROCEDURES: * LAPAROSCOPIC APPENDECTOMIES * LAPAROSCOPIC & ROBOTIC CHOLECYSTECTOMIES * TRAUMA SERVICES * LAPAROSCOPIC & ROBOTIC HERNIA REPAIRS * BREAST LESION EXCISION & MASTECTOMIES * BARIATRIC SURGERIES MAJOR GENERAL PEDIATRIC PROCEDURES/SERVICES: * THE MAIN OR PROUDLY SERVICES HSHS ST. JOHN'S CHILDREN'S HOSPITAL & NICU - BOTH ARE REGIONAL FACILITIES * APPENDECTOMIES * BOWEL RESECTIONS * PYLORMYOTOMIES * HERNIA REPAIRS MAJOR UROLOGY PROCEDURES: * KIDNEY/BLADDER STONE PROCEDURES, INCLUDING: EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY (ESWL), PERCUTANEOUS NEPHROLITHOTOMY, AND A COMPREHENSIVE LASER PROGRAM * PENILE PROSTHESIS * TURP/TUR-BT * ROBOTIC NEPHRECTOMIES, NEPHROURETERECTOMIES, ADRENALECTOMIES, PYELOPLASTIES & PROSTATECTOMIES MAJOR PEDIATRIC UROLOGY PROCEDURES: * CIRCUMCISION REVISIONS/PHIMOSIS/HIDDEN PENIS REPAIRS * HERNIA REPAIRS * ORCHIPEXIES * HYPOSPADIUS REPAIRS MAJOR GYNECOLOGICAL & GYNE-ONC PROCEDURES: * LAPAROSCOPIC & ROBOTIC HYSTERECTOMIES/BSO * COMPREHENSIVE GYNE-ONC PROGRAM - PRIMARILY PERFORMED ROBOTICALLY * WOMEN'S URO/GYN PROGRAM, INCLUDING: VAGINAL SLINGS, BLADDER STIMULATORS, ROBOTIC COLPOPEXY & COLPORRHAPHIES MAJOR ENT PROCEDURES: * ENDOSCOPIC/IMAGE GUIDED SINUS SURGERIES * PEDIATRIC AIRWAY PROCEDURES, INCLUDING: TRACHEOSTOMY CARE, BRONCHOSCOPIES, LARYNGOSCOPIES, BALLOON DILATIONS * ENT CANCER SURGERY MAJOR NEUROSURGERY PROCEDURES: * COMPREHENSIVE DEEP BRAIN STIMULATOR PROGRAM * SPINE PROCEDURES * VP SHUNT PLACEMENT & MAINTENANCE * VAGAL NERVE STIMULATOR PLACEMENT & MAINTENANCE * BRAIN BIOPSIES AND CRANIOTOMY/TUMOR RESECTIONS * KYPHOPLASTIES * TRAUMA SERVICES MAJOR OPHTHALMOLOGY PROCEDURES: * COMPREHENSIVE RETINAL PROGRAM * CATARACT PROCEDURES * OCULOPLASTICS PROGRAM, INCLUDING: BLEPHAROPLASTIES, BROW LIFTS & MUSCLE REPAIR PROCEDURES ROBOTIC SERVICES: * SURGEONS FROM GENERAL SURGERY, UROLOGY & GYNECOLOGY PERFORM ROBOTIC PROCEDURES. ST. JOHN'S OWNS TWO INTUITIVE SURGICAL DAVINCI ROBOTS. ROBOTICS MAKES UP 15.6% OF THE BUSINESS FOR THOSE SPECIALTIES. ST. JOHN'S PERFORMED 475 ROBOTIC CASES IN FY22 WITH AN AVERAGE COST PER CASE OF $2,999.45 WITH TOTAL COST OF $1,424,738.28. TOP 3 SERVICE LINES FOR CC 7041 - BY VOLUME: * ORTHOPEDICS - 3,501 CASES (INCLUDES ROBOTIC ORTHO AND PEDIATRICS) * GENERAL SURGERY (INCLUDES PEDIATRICS AND TRAUMA) - 1,418 * UROLOGY (INCLUDES PEDIATRICS) - 1,309 CASES TOP 3 SERVICE LINES FOR CC7041 - BY TOTAL $ SPEND ON SUPPLIES/IMPLANTS & AVERAGE COST PER CASE: * ORTHOPEDICS (INCLUDES ROBOTIC ORTHO AND PEDIATRICS) O TOTAL $ SPENT ON SUPPLIES/IMPLANTS = $ 15,540,063.48 O AVERAGE COST/CASE = $4,438.75 * GENERAL (INCLUDES PEDIATRIC) O TOTAL $ SPENT ON SUPPLIES/IMPLANTS = $4,167,292.12 O AVERAGE COST/CASE = $2,938.85 * ROBOTIC O TOTAL $ SPENT ON SUPPLIES/IMPLANTS = $1,424,738.28 O AVERAGE COST/CASE = $2,999.45
IN FY22, THE MAJORITY OF THE INTERNAL MEDICINE CASES THAT WERE ADMITTED TO ST. JOHN'S HOSPITAL CAME THROUGH OUR EMERGENCY DEPARTMENT (52%), WHILE 36% CAME TO OUR FACILITY AS DIRECT ADMITS FROM OUR CONNECT PROGRAM. THE EMERGENCY ROOM IS A LEVEL 1 TRAUMA CENTER THAT SERVICES CENTRAL ILLINOIS. THE TOTAL VISIT VOLUME IS APPROXIMATELY 50,400 WITH A 21% ADMISSION RATE. THE CONNECT PROGRAM IS A REGIONAL REFERRAL PROGRAM THAT STARTED IN 2010. THE PROGRAM IS A ONE-CALL SYSTEM THAT FOCUSES ON PHYSICIAN ALIGNMENT AND CLINICAL PROTOCOLS. ST. JOHN'S HAS A DEDICATED OUTREACH REPRESENTATIVE THAT WORKS WITH REFERRING HOSPITALS TO ADDRESS ANY ISSUES AND TO IMPROVE THE SERVICES. ST. JOHN'S HAS TWO HOSPITALIST GROUPS SERVICING THE PATIENTS: HSHS MEDICAL GROUP (WHICH HAS GROWN SIGNIFICANTLY OVER THE PAST 5 - 6 YEARS) AND SPRINGFIELD CLINIC. THIS PROGRAM ENABLES THE HOSPITALIST TO MANAGE THE IN-HOSPITAL CARE FOR PATIENTS AND COORDINATES CARE WITH OTHER CONSULTING MD'S, IF NEEDED. AN EFFECTIVE HOSPITALIST PROGRAM CAN BENEFIT HOSPITALS BY REDUCING LENGTH OF STAY, IMPROVING HOSPITAL EFFICIENCIES, AND IMPROVING QUALITY CARE. THIS PROGRAM ALSO ENABLES PRIMARY CARE MD'S TO REDUCE TIME AT THE HOSPITAL AND SPEND MORE TIME AT THEIR PRACTICE. HSHS MEDICAL GROUP HOSPITALISTS MANAGED THE HIGHEST PERCENTAGE OF INTERNAL MEDICINE INPATIENTS IN FY22 WITH 33% OF INTERNAL MEDICINE CASES WHILE SPRINGFIELD CLINIC PHYSICIANS WITH INTERNAL MEDICINE SPECIALTY AT 28%.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Name Not Listed 2021 & 2022 Vice Chair | OfficerTrustee | 1 | $0 |
Name Not Listed President & Division CEO - Illinois (until Jan 2022) | OfficerTrustee | 27 | $0 |
Name Not Listed 2021 & 2022 Secretary/hshs Sister | OfficerTrustee | 1 | $0 |
Name Not Listed Ceo/president (until Nov 2021) | OfficerTrustee | 60 | $0 |
Name Not Listed 2021 & 2022 Chair | OfficerTrustee | 1 | $0 |
Name Not Listed Board Member | Trustee | 1 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Southern Il University School Of Medicine Physicians | 6/29/22 | $25,582,477 |
Harold O'shea Builders Construction | 6/29/22 | $19,596,620 |
Medical Solutions Contract Labor | 6/29/22 | $8,740,152 |
Shearwater Health Inc Contract Labor | 6/29/22 | $5,073,319 |
Springfield Clinic Llp Physicians | 6/29/22 | $14,776,289 |
Statement of Revenue | |
---|---|
Total Revenue from Contributions, Gifts, Grants & Similar | $7,254,713 |
Investment income | $1,072,086 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $216,194 |
Net Gain/Loss on Asset Sales | $2,380,025 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $602,839,842 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic individuals. | $21,090 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $483,668 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $141,399,111 |
Pension plan accruals and contributions | $10,158,797 |
Other employee benefits | $23,841,352 |
Payroll taxes | $10,691,061 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $0 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $1,635,158 |
Fees for services: Other | $151,112,465 |
Advertising and promotion | $729,600 |
Office expenses | $199,443 |
Information technology | $29,871,997 |
Royalties | $0 |
Occupancy | $13,208,141 |
Travel | $1,281,734 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $129,957 |
Interest | $3,046,128 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $26,341,322 |
Insurance | $6,665,170 |
All other expenses | $0 |
Total functional expenses | $568,864,760 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $0 |
Savings and temporary cash investments | $3,122,681 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $92,337,038 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $14,574,669 |
Prepaid expenses and deferred charges | $3,782,690 |
Investments—publicly traded securities | $86,223,829 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $15,439,874 |
Total assets | $636,225,887 |
Accounts payable and accrued expenses | $142,207,318 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $214,524,180 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $138,696,251 |
Total liabilities | $495,427,749 |
Net assets without donor restrictions | $0 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Total liabilities and net assets/fund balances | $140,798,138 |